News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
ACTOR, PHILLIP VAN LEAR, SHARES HIS GLAUCOMA JOURNEY
To support World Glaucoma Week, on behalf of Heidelberg Engineering, Janice English interviewed Phillip Van Lear to raise awareness of the importance of early detection of glaucoma and treatment at the right time. Read about his personal journey and share it with your patients.
Read moreTHE TECHNOLOGICAL FIGHT AGAINST THE SILENT THIEF OF SIGHT
Advances in optical coherence tomography (OCT) technology, new treatments and innovative research are contributing to earlier detection of glaucoma. Uncover more about the importance of patient awareness, confident diagnosis and treatment at the right time in this captivating interview with Dr. Christian Mardin, Consultant Ophthalmologist at the Friedrich-Alexander University Erlangen-Nuremberg and Dr. Sanjay Asrani, Professor of Ophthalmology at Duke Eye Centre, North Carolina.
Read moreDr. Arturo Chayet: Transforming Ophthalmology practice with ANTERION® with swept-source OCT Technology
In this interview Dr. Arturo Chayet shares his experience on the implementation of ANTERION® with swept-source OCT technology in his medical practice.
Read more“AT RISK CORNEAS” ARE MORE EASILY IDENTIFIED WITH SCORE
Risk assessment of post-LASIK corneal ectasia in refractive surgery patients is now a more exact, objective, evaluation thanks to the work of Heidelberg Engineering and a leading research partner in Paris.
Read moreANTERION PLAYS SIGNIFICANT ROLE IN PREMIUM IOL SELECTION
Accessing additional data for premium IOL selection is essential for patient satisfaction, and this is where the recently FDA-approved Heidelberg Engineering’s ANTERION can play a valuable role.
Read moreHow ANTERION can support clinicians in complex cataract surgery planning
ANTERION® from Heidelberg Engineering is a comprehensive all-in-one-solution for optical biometry and IOL power predictions. ANTERION provides high-resolution images of the anterior segment by combining SS-OCT technology with eye tracking.
Read moreThe importance of multimodal imaging in the diagnosis of AMD and geographic atrophy
The U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA) for the first time, one of the advanced forms of dry age-related macular degeneration (AMD). The approval is considered a breakthrough in ophthalmology and finally gives patients hope of positively impacting the course of the disease.
Read moreHeidelberg Engineering appoints new distribution partner in Türkiye
Since January 1, 2023, OCULAMED Medikal Elektronik Ltd. Sti serves as the new official distribution partner in Türkiye for the growing product portfolio of Heidelberg Engineering and will continue to deliver the high standard of support and education our customers have come to expect.
Read moreOCT Biomarkers of Intermediate Age-Related Macular Degeneration (iAMD) and Their Correlation with Atrophy Development
This journal article highlights the value of SPECTRALIS OCT volume scans in identifying biomarkers of age-related macular degeneration.
Read moreOIS Podcast Episode on Heidelberg Engineering: Setting the Standards in Imaging
Sophia Pathai, MD, PhD, host of the Ophthalmic Innovation Source podcast, caught up with our Head of Corporate Strategy and Managing Director of MSI, Kfir Azoulay, as well as Tosh Vadhia, Managing Director of Heidelberg Engineering UK, to talk about the trends and opportunities in ophthalmology, including OCT-based biomarkers and artificial intelligence.
Read more